Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease (FUNGRAPE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01449110
Recruitment Status : Completed
First Posted : October 7, 2011
Last Update Posted : November 16, 2011
Sponsor:
Collaborator:
Hospital General Universitario Morales Meseguer
Information provided by (Responsible Party):
Juan Carlos Espín de Gea, National Research Council, Spain

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2010
Actual Study Completion Date : March 2011